Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells
Authors:
- 1 September 2021
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 907, 174249
Abstract
No abstract availableKeywords
Funding Information
- University of Florida
This publication has 30 references indexed in Scilit:
- Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2aAmerican Journal of Physiology-Cell Physiology, 2013
- GLP-1 analogue, Liraglutide protects human umbilical vein endothelial cells against high glucose induced endoplasmic reticulum stressRegulatory Peptides, 2012
- Hyperglycemia-induced endoplasmic reticulum stress in endothelial cellsNutrition, 2010
- Glucagon-Like Peptide-1 Agonists Protect Pancreatic β-Cells From Lipotoxic Endoplasmic Reticulum Stress Through Upregulation of BiP and JunBDiabetes, 2009
- Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular CausesNew England Journal of Medicine, 2007
- Protection of pancreatic β-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studiesJournal of Endocrinology, 2007
- Real-time detection and continuous monitoring of ER stress in vitro and in vivo by ES-TRAP: evidence for systemic, transient ER stress during endotoxemiaNucleic Acids Research, 2006
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemiaJournal of Immunological Methods, 1994
- Measurement of protein using bicinchoninic acidAnalytical Biochemistry, 1985